Search Results

2021 Clarivate Analytics Highly Cited Researcher in two disciplines: Pharmacology & Toxicology and Biology & Biochemistry, a corresponding member of the International Union of Basic and Clinical Pharmacology Sexton is also a co-founder of the San Francisco-based biotechnology company Septerna Inc . Dr. Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Claudia Stäubert "I received my degree in biochemistry from Leipzig University (Germany) being already Since 2014, I have led a research group at the Rudolf Schönheimer Institute of Biochemistry in Leipzig Claudia Stäubert on the web Stäubert Lab, Rudolf Schönheimer Institute of Biochemistry Leipzig LinkedIn Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

He works in a multidisciplinary Chemical Biology team based at the recently established US R&D hub in Originally from Łódź, Poland, Jacek completed his Master's degree in Biology, specializing in Biochemistry Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

After spending two years at the Cleveland Institute of Art, he earned degrees in Biochemistry and Chemistry He then went on to earn a Ph.D. in Molecular Biophysics from Johns Hopkins University, followed by postdocs Miller School of Medicine in 2016, where he is currently a practicing molecular pharmacologist and biophysicist , systems and synthetic biologist, technologist, heavy CRISPR user, protein sequence- and structure-based Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

He later joined the laboratory of eminent biochemical pharmacologist, Dr. Alfred G. His training has provided a strong foundation and appreciation for the applications of pharmacology, biochemistry and structural biology to delineate mechanisms of action. The Sunahara lab utilizes biochemical, biophysical and pharmacological methodologies to study GPCR-G Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Moro, that he truly saw how molecules could go beyond the bench and interact with biology in powerful The Moment Chemistry Met Biology Nicoli’s turning point came when he realized that molecules weren’t static—they could act , bind , and modulate biological targets. For Nicoli, chemistry became more than reactions—it became a bridge to biological insight. Alessandro Nicoli on the web Leibniz Institute for Food Systems Biology at the Technical University of

Oliver Hartley Oliver Hartley is VP for Drug Discovery at Orion Biotechnology . Trained as a biochemist, he completed a PhD in protein engineering (Cambridge, UK) with Sir Gregory Winter Oliver Hartley on the web LinkedIn Orion Biotechnology Dr. Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

FB is recognized for her expertise and pioneering works in the field of biological and pathological functions Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Following this tremendous experience, he was recruited to be the Principal Investigator of the Receptor Biology To broaden his biomedical skill-set Stuart next accepted the position of Head of the Receptor Pharmacology Adjunct Director of the VIB Center for Molecular Neurology and also Vice-Chair of the Department of Biomedical Stuart’s current research, in the Receptor Biology Lab, focuses on the development of novel GPCR-based Maudsley on the web Maudsley Lab LinkedIn Google Scholar ResearchGate Maudsley Lab on Facebook Receptor Biology

Foord reflects on his path from academic neuroendocrinology to introducing molecular biology and molecular pharmacology into Glaxo’s GPCR programs, and on the combination of rigor, bioinformatics, and serendipity Deorphanizing Receptors Blends Bioinformatics and Bench Work . Dr. As Head of Bioinformatics for Neuroscience, Dr. Reflecting on his path from physiology to molecular pharmacology to bioinformatics, Dr.

Kaavya Krishna Kumar on the web Journal of Biology Chemistry Stanford University Google Scholar LinkedIn Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Brian Hudson About Brian Hudson Brian is a lecturer in the School of Molecular Biosciences at the University Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

We have developed an array of fluorescent biosensors to map kinase activity in living cells and are exploring Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Advanced GPCR webinars for pharmacologists and biotech scientists. Live Q&A. GPCR webinars are free, live online scientific sessions focused on G protein-coupled receptor biology Whether you're deep in receptor biology or evaluating assay tools, these sessions are built for you. Every session is grounded in receptor biology with a focus on what's practical and applicable. A working understanding of GPCR biology helps you get the most from each session.

talk about how I support GPCR discovery, pharmacology strategy, and cross-functional execution across biotech

non-psychedelic psychedelic for depression — and why the real bottleneck in GPCR drug discovery is the biology He earned his MD and biochemistry PhD at St. Louis University and trained in pharmacology at NIH and in molecular biology and psychiatry at Stanford It reframes the field's task from finding good targets to understanding the biology well enough to connect After receiving his MD and Ph.D. in Biochemistry from St.

Arun Shukla leads a structural pharmacology lab in the Department of Biological Sciences and Bioengineering He completed his PhD at the Max Planck Institute of Biophysics in Frankfurt and postdoctoral training Episode Timeline 00:00 Introduction 02:15 From DNA quadruplexes to GPCR structural biology 06:32 The Sciences and Bioengineering. a biochemistry class where he learned about cell signaling that he became curious and wanted to learn

Biotech Decision Vault by Attila Foris Strategic Business & Operating Systems Advisor Dr.

GPCR was created to break down barriers across academia, biotech, pharma, and CROs—so knowledge, tools field , including: Academic researchers (PI, postdoc, student) Industry scientists and R&D leaders Biotech

is an online platform that provides to (i) individuals and businesses such as scientists, students, biotech others with access to advertise, to promote, and market their services and products related to the biotech

What challenges do you face most in your research or biotech journey?

As a strtegic partner, you'll gain trusted access to an engaged audience of academic researchers, biotech partner, you'll be featured across our nonprofit platform, trusted by thousands of GPCR scientists and biotech Social Media Promotion ✓ Engaging posts about your organization ✓ Targeted to GPCR researchers and biotech

GPCR Retreat — an immersive event uniting scientists, biotech leaders, and innovators in GPCR research

investigators from academia and industry to discuss and debate existing and novel concepts in GPCR biology

Up Equip Your Team with Terry Kenakin’s Pharmacology Frameworks Used by discovery scientists across biotech Terry’s Corner lessons and analysis • Ability to suggest topics relevant to your programs • Access for biotech

curated intelligence briefings with expert analysis Community access — connect with scientists and biotech